Global Rosuvastatin Calcium Market Data Survey Report 2013-2025
Table of Contents
1 Global Market Overview
- 1.1 Scope of Statistics
- 1.1.1 Scope of Products
- 1.1.2 Scope of Manufacturers
- 1.1.3 Scope of Application
- 1.1.4 Scope of Type
- 1.1.5 Scope of Regions/Countries
- 1.2 Global Market Size
2 Regional Market
- 2.1 Regional Production
- 2.2 Regional Demand
- 2.3 Regional Trade
3 Key Manufacturers
- 3.1 AstraZeneca
- 3.1.1 Company Information
- 3.1.2 Product & Services
- 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.1.4 Recent Development
- 3.2 Teva Pharmaceutical Industries
- 3.2.1 Company Information
- 3.2.2 Product & Services
- 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.2.4 Recent Development
- 3.3 MSN Laboratories
- 3.3.1 Company Information
- 3.3.2 Product & Services
- 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.3.4 Recent Development
- 3.4 Cadila Pharmaceuticals
- 3.4.1 Company Information
- 3.4.2 Product & Services
- 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.4.4 Recent Development
- 3.5 LGM Pharma
- 3.5.1 Company Information
- 3.5.2 Product & Services
- 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.5.4 Recent Development
- 3.6 Bal Pharma
- 3.6.1 Company Information
- 3.6.2 Product & Services
- 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.6.4 Recent Development
- 3.7 Changzhou Pharmaceutical Factory
- 3.7.1 Company Information
- 3.7.2 Product & Services
- 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.7.4 Recent Development
- 3.8 Jingxin Pharm
- 3.8.1 Company Information
- 3.8.2 Product & Services
- 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.8.4 Recent Development
- 3.9 Zhejiang Hisun Pharmaceutical
- 3.9.1 Company Information
- 3.9.2 Product & Services
- 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.9.4 Recent Development
- 3.10 HEC Pharm
- 3.10.1 Company Information
- 3.10.2 Product & Services
- 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.10.4 Recent Development
- 3.11 Lunan Pharmaceutical
- 3.11.1 Company Information
- 3.11.2 Product & Services
- 3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.11.4 Recent Development
- 3.12 Nanjing Frochem Tech
- 3.12.1 Company Information
- 3.12.2 Product & Services
- 3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.12.4 Recent Development
- 3.13 Lianyungang Runzhong Pharmaceutical
- 3.13.1 Company Information
- 3.13.2 Product & Services
- 3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.13.4 Recent Development
- 3.14 Shandong Bechem Chemicals
- 3.14.1 Company Information
- 3.14.2 Product & Services
- 3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.15 CTX Life Sciences
- 3.15.1 Company Information
- 3.15.2 Product & Services
- 3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
- 4.1 Tablet (including dispersible tablet and general tablet)
- 4.1.1 Overview
- 4.1.2 Tablet (including dispersible tablet and general tablet) Market Size and Forecast
- 4.2 Capsule
- 4.2.1 Overview
- 4.2.2 Capsule Market Size and Forecast
- 4.3 Others
- 4.3.1 Overview
- 4.3.2 Others Market Size and Forecast
5 Market by Type
5.By Purity 98.0%
- 5.1 Purity 98.0%
- 5.1.1 Overview
- 5.1.2 Purity 98.0% Market Size and Forecast
- 5.2 Purity 99.0%
- 5.2.1 Overview
- 5.2.2 Purity 99.0% Market Size and Forecast
- 5.3 Others
- 5.3.1 Overview
- 5.3.2 Others Market Size and Forecast
6 Price Overview
- 6.1 Price by Manufacturers
- 6.2 Price by Application
- 6.3 Price by Type
7 Conclusion
Summary
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2.
The global Rosuvastatin Calcium market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm
Lunan Pharmaceutical
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Shandong Bechem Chemicals
CTX Life Sciences
Major applications as follows:
Tablet (including dispersible tablet and general tablet)
Capsule
Others
Major Type as follows:
Purity 98.0%
Purity 99.0%
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa